Skip to main content
. 2018 May 8;9(35):24081–24096. doi: 10.18632/oncotarget.25300

Figure 1. Venn diagram showing the distribution of KRAS, NRAS, TP53 and BRAF mutations in the 87 sporadic colorectal cancer (sCRC) patients analysed in this study.

Figure 1

The number of mutated cases for each mutational profile is shown between brackets.